Immunogenicity and safety of an investigational protein-based pneumococcal vaccine in infants following 3+0 and 2+1 vaccination schedules: a phase ii randomized trial in the gambia
crossref(2016)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
crossref(2016)